Feed Preview

Fast Growing

Inflammation and Immunity in Schizophrenia

Inflammation and Immunity in Schizophrenia diagram by

Schizophrenia is a complex mental disease caused by a combination of serial alterations in genetic and environmental factors, including inflammation and immunity. Here is the latest research.

Top 20 most recent papers
Pharmacology & Therapeutics

Oxidation-reduction mechanisms in psychiatric disorders: A novel target for pharmacological intervention

Pharmacology & TherapeuticsMarch 14, 2020
Andrea Carlo RossettiRaffaella Molteni
Frontiers in Neuroscience

Complement System in Brain Architecture and Neurodevelopmental Disorders

Frontiers in NeuroscienceMarch 3, 2020
Juliana MagdalonAndréa Laurato Sertié
Acta Neuropsychiatrica

Monocyte count in schizophrenia and related disorders: a systematic review and meta-analysis

Acta NeuropsychiatricaMarch 18, 2020
Mario Gennaro MazzaMassimo Clerici
The Psychiatric Quarterly

Galectin-1 and Galectin-3 Levels in Patients with Schizophrenia and their Unaffected Siblings

The Psychiatric QuarterlyMarch 12, 2020
Rabia Nazik YükselErol Göka
European Psychiatry : the Journal of the Association of European Psychiatrists

Nutritional ketosis as an intervention to relieve astrogliosis: Possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disorders

European Psychiatry : the Journal of the Association of European PsychiatristsFebruary 26, 2020
Gerwyn MorrisBasant K Puri
Brain, Behavior, and Immunity

Resolution of chronic inflammation as a new adjunctive approach in schizophrenia treatment

Brain, Behavior, and ImmunityApril 1, 2020
Alexander KalinkovichGregory Livshits
Early Intervention in Psychiatry

Changes in inflammation are related to depression and amount of aerobic exercise in first episode schizophrenia

Early Intervention in PsychiatryFebruary 15, 2020
Joseph VenturaKeith H Nuechterlein
Georgian Medical News


Georgian Medical NewsMarch 7, 2020
M GhonghadzeN Gongadze
International Journal of Molecular Sciences

Innate Immunity: A Common Denominator between Neurodegenerative and Neuropsychiatric Diseases

International Journal of Molecular SciencesFebruary 13, 2020
Fabiana NovellinoGiuseppe Donato
Current Medicinal Chemistry

The emerging role of atrial natriuretic peptide in psychiatry

Current Medicinal ChemistryFebruary 20, 2020
Donatella MarazzitiLiliana Dell'Osso
Frontiers in Pharmacology

Alterations of Astrocytes in the Context of Schizophrenic Dementia

Frontiers in PharmacologyMarch 3, 2020
Vadim V TarasovGjumrakch Aliev
Journal of Neuroinflammation

Clozapine reduces infiltration into the CNS by targeting migration in experimental autoimmune encephalomyelitis

Journal of NeuroinflammationFebruary 14, 2020
Katharina RobichonAnne Camille La Flamme
Translational Psychiatry

Genetic associations with clozapine-induced myocarditis in patients with schizophrenia

Translational PsychiatryFebruary 19, 2020
Paul LacazeMunir Pirmohamed

See more papers from this feed

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.


Catatonia is a psychomotor syndrome with motor and behavioral symptoms, and can occur in both patients with or without psychiatric illness. Discover the latest research on Catatonia here.

Catatonic Schizophrenia

Catatonia is a psychomotor symptom in which patients present with stupor, although catatonic excitement may also present at the other end of the spectrum. Catatonia has been historically associated with schizophrenia although it is also associated with other neuropsychiatric disorders. Find the latest research on catatonic schizophrenia here.

Comorbidity In Psychiatry

There is ongoing debate regarding the handling of comorbidity in psychiatric disorders, and determining whether the issue lies with the categorizations of diagnostic conventions or if there is an underlying pathology that links multiple diseases. Understanding how to give the proper diagnosis/diagnoses would allow for optimal management of the patient. Find the latest research on comorbidity in psychiatry here.

Epigenetics & Psychiatry

Psychiatric disorders are known to be multifaceted in their pathophysiology. Because epigenetic changes can be sensitive to the environment, inherited, and reversible, the study of epigenetics in psychiatric disease is a logical way to understand the natural history of the disease as well as to develop therapeutics. Find the latest research on epigenetics and psychiatry here.

Forensic Psychiatry

Forensic psychiatry includes the relationship between psychiatric abnormalities and legal violations and crimes. Discover the latest research on forensic psychiatry here.


Neuropsychiatry is an emerging field at the intersection of neurology and psychiatry, driven by the unprecedented advances in neuroscience. Here are the latest discoveries in neuropsychiatry.

Paranoid Disorders

Paranoid disorders are psychiatric disorders with the suspicion and belief that others are plotting against them, leading to mistrust of others. These symptoms of paranoia can be seen in other psychiatric disorders including dementia and schizophrenia. Here is the latest research on paranoid disorders.

Personality Disorders

Personality disorders are a class of mental disorders characterized by enduring maladaptive patterns of behavior, cognition, and inner experience, exhibited across many contexts and deviating from those accepted by the individual's culture. Discover the latest research on personality disorders here.

© 2020 Meta ULC. All rights reserved